Cargando…
Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822855/ https://www.ncbi.nlm.nih.gov/pubmed/35130919 http://dx.doi.org/10.1186/s12936-022-04049-1 |
| _version_ | 1784646688739164160 |
|---|---|
| author | Ebong, Chris Sserwanga, Asadu Namuganga, Jane Frances Kapisi, James Mpimbaza, Arthur Gonahasa, Samuel Asua, Victor Gudoi, Sam Kigozi, Ruth Tibenderana, James Bwanika, John Bosco Bosco, Agaba Rubahika, Denis Kyabayinze, Daniel Opigo, Jimmy Rutazana, Damian Sebikaari, Gloria Belay, Kassahun Niang, Mame Halsey, Eric S. Moriarty, Leah F. Lucchi, Naomi W. Souza, Samaly S. Svigel Nsobya, Sam L. Kamya, Moses R. Yeka, Adoke |
| author_facet | Ebong, Chris Sserwanga, Asadu Namuganga, Jane Frances Kapisi, James Mpimbaza, Arthur Gonahasa, Samuel Asua, Victor Gudoi, Sam Kigozi, Ruth Tibenderana, James Bwanika, John Bosco Bosco, Agaba Rubahika, Denis Kyabayinze, Daniel Opigo, Jimmy Rutazana, Damian Sebikaari, Gloria Belay, Kassahun Niang, Mame Halsey, Eric S. Moriarty, Leah F. Lucchi, Naomi W. Souza, Samaly S. Svigel Nsobya, Sam L. Kamya, Moses R. Yeka, Adoke |
| author_sort | Ebong, Chris |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8822855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88228552022-02-09 Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda Ebong, Chris Sserwanga, Asadu Namuganga, Jane Frances Kapisi, James Mpimbaza, Arthur Gonahasa, Samuel Asua, Victor Gudoi, Sam Kigozi, Ruth Tibenderana, James Bwanika, John Bosco Bosco, Agaba Rubahika, Denis Kyabayinze, Daniel Opigo, Jimmy Rutazana, Damian Sebikaari, Gloria Belay, Kassahun Niang, Mame Halsey, Eric S. Moriarty, Leah F. Lucchi, Naomi W. Souza, Samaly S. Svigel Nsobya, Sam L. Kamya, Moses R. Yeka, Adoke Malar J Correction BioMed Central 2022-02-07 /pmc/articles/PMC8822855/ /pubmed/35130919 http://dx.doi.org/10.1186/s12936-022-04049-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ebong, Chris Sserwanga, Asadu Namuganga, Jane Frances Kapisi, James Mpimbaza, Arthur Gonahasa, Samuel Asua, Victor Gudoi, Sam Kigozi, Ruth Tibenderana, James Bwanika, John Bosco Bosco, Agaba Rubahika, Denis Kyabayinze, Daniel Opigo, Jimmy Rutazana, Damian Sebikaari, Gloria Belay, Kassahun Niang, Mame Halsey, Eric S. Moriarty, Leah F. Lucchi, Naomi W. Souza, Samaly S. Svigel Nsobya, Sam L. Kamya, Moses R. Yeka, Adoke Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title | Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title_full | Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title_fullStr | Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title_full_unstemmed | Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title_short | Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda |
| title_sort | correction to: efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in uganda |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822855/ https://www.ncbi.nlm.nih.gov/pubmed/35130919 http://dx.doi.org/10.1186/s12936-022-04049-1 |
| work_keys_str_mv | AT ebongchris correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT sserwangaasadu correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT namugangajanefrances correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT kapisijames correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT mpimbazaarthur correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT gonahasasamuel correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT asuavictor correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT gudoisam correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT kigoziruth correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT tibenderanajames correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT bwanikajohnbosco correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT boscoagaba correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT rubahikadenis correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT kyabayinzedaniel correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT opigojimmy correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT rutazanadamian correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT sebikaarigloria correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT belaykassahun correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT niangmame correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT halseyerics correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT moriartyleahf correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT lucchinaomiw correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT souzasamalyssvigel correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT nsobyasaml correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT kamyamosesr correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda AT yekaadoke correctiontoefficacyandsafetyofartemetherlumefantrineanddihydroartemisininpiperaquineforthetreatmentofuncomplicatedplasmodiumfalciparummalariaandprevalenceofmolecularmarkersassociatedwithartemisininandpartnerdrugresistanceinuganda |